MIAMI, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today plans to offer access to two premier psilocybin-guided wellness retreats through its wholly owned subsidiary, Mycotopia Therapy which will act as booking site for the partner retreat centers. The retreats will be located in Jamaica www.mycomeditations.com and Amsterdam www.psychedelicinsights.com. Both of the premier psilocybin-guided wellness retreats will be supervised by highly qualified medical professionals. The primary focus of the retreats will be to serve as a means of improving the mental health of individuals suffering from anxiety, OCD, treatment-resistant depression, addiction, and anxiety and depression related to terminal illness. Ehave's premier psilocybin-guided wellness retreats are not to be confused with recreational drug use. The retreats are a controlled process guided by trained and licensed counselors using psychedelics as self-exploratory and therapeutic plant medicine. Ehave will be the booking partner and expects to list additional retreats for more consumer options.
Market Data 
Markets 
AI
